The Life Sciences Virtual Investor Forum, co-hosted by B2i Digital, Inc. and Zacks Small-Cap Research, will take place on June 24 and 25, 2026, featuring presentations from 24 public companies spanning biotechnology, diagnostics, medical devices, and digital health. The event, a B2i Digital Featured Conference, aims to provide investors with efficient, direct access to management teams developing therapies and technologies in the life sciences sector.
B2i Digital, as the Official Marketing Partner, brings the forum into its ecosystem, leveraging a distribution and media engine that drives qualified investors to the presentations and one-on-one meetings. Before, during, and after the two days, B2i amplifies the event across its platform, reaching a proprietary network of more than 1.7 million retail and institutional market participants. The same visibility engine has carried more than 115 investor conferences, according to the company.
Zacks Small-Cap Research, a preferred provider in the OTC Markets Group's Research Marketplace, prepares independent company-sponsored research and related content for distribution across investor and media channels. Its team of life sciences analysts supports the forum as co-host.
The two-day lineup includes clinical-stage biotechnology, rare-disease and oncology therapeutics, molecular diagnostics, medical devices, veterinary medicine, nutrition science, and AI-powered digital health. Each company has 30 minutes for a live presentation and Q&A. One-on-one meeting requests are available through the VIC site, with replays available on B2i Digital and OTC Markets YouTube channels.
Life sciences investors want efficient, direct access to management teams developing the therapies and technologies that matter, said David Shapiro, Chief Executive Officer of B2i Digital. Pairing that access with independent research from Zacks makes the forum more valuable on both sides. Over two days, investors can meet companies across biotech, diagnostics, devices, and digital health, and reach their own conclusions.
Presenting companies on Day One (June 24) include Protalix BioTherapeutics, MetaVia Inc., CytoSorbents Corporation, PetVivo Holdings, Jaguar Health, Reviva Pharmaceuticals, and 4DMedical. Day Two (June 25) features Prostatype Genomics, Abingdon Health, Innovotech, Lakewood-Amedex Biotherapeutics, Nasus Pharma, Kelyniam Global, IMUNON, Promino Nutritional Sciences, Envoy Medical, Coiled Therapeutics, Aspire Biopharma, Rocket Doctor AI, Phio Pharmaceuticals, aTyr Pharma, and NuFarm.
To request one-on-one meetings with management, visit this link. For more details, see B2i Digital's event page. Registration and company profiles are available at Virtual Investor Conferences.
Throughout the year, Virtual Investor Conferences feature public companies from exchanges worldwide, including NYSE, Nasdaq, TSX, TSXV, CSE, ASX, LSE, and the OTC Markets. Virtual Investor Conferences is an OTC Markets Group Inc. property.
